Rapid Initiation of Intravenous Epoprostenol Infusion Is the Favored Option in Patients with Advanced Pulmonary Arterial Hypertension

BACKGROUND: Intravenous infusion (IVI) of epoprostenol is an effective treatment for patients with advanced pulmonary arterial hypertension (PAH). However, there is no widely accepted standard method for initiating the IVI therapy. This study evaluated the hemodynamic improvements achieved with IVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Mai, Tamura, Yuichi, Takei, Makoto, Yamamoto, Tsunehisa, Ono, Tomohiko, Kuwana, Masataka, Fukuda, Keiichi, Satoh, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386822/
https://www.ncbi.nlm.nih.gov/pubmed/25844932
http://dx.doi.org/10.1371/journal.pone.0121894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386822/
https://www.ncbi.nlm.nih.gov/pubmed/25844932
http://dx.doi.org/10.1371/journal.pone.0121894

Ejemplares similares